Christopher K. Rushton

Burnaby, BC V5A1S6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.

Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.

Journal: Cell reports

Published: February 19, 2026

LCR-modules: a collection of workflows for cancer genome analysis.

LCR-modules: a collection of workflows for cancer genome analysis.

Journal: Bioinformatics (Oxford, England)

Published: October 16, 2025

A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma.

A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma.

Journal: British journal of haematology

Published: May 17, 2024

Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.

Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 15, 2023

Relapse timing is associated with distinct evolutionary dynamics in DLBCL.

Relapse timing is associated with distinct evolutionary dynamics in DLBCL.

Journal: medRxiv : the preprint server for health sciences

Published: March 22, 2023

Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns.

Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns.

Journal: Blood

Published: October 12, 2022

Concerning data inconsistencies in Burkitt lymphoma genome study.

Concerning data inconsistencies in Burkitt lymphoma genome study.

Journal: Blood

Published: March 30, 2022

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.

Journal: Blood advances

Published: March 17, 2021

Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.

Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.

Journal: Cell reports

Published: March 09, 2021

PRPS-ST: A protocol-agnostic self-training method for gene expression-based classification of blood cancers.

PRPS-ST: A protocol-agnostic self-training method for gene expression-based classification of blood cancers.

Journal: Blood cancer discovery

Published: January 04, 2021

Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors.

Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors.

Journal: Blood advances

Published: July 24, 2020

Characterization of DLBCL with a PMBL gene expression signature.

Characterization of DLBCL with a PMBL gene expression signature.

Journal: Blood

Published: June 15, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026